Baird Financial Group, Inc. Adma Biologics, Inc. Put Options Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
397Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$289 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$199 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$187 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$91.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.04B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...